The import of pharmaceutical goods to Singapore showed significant growth over the past decade. From 2013 to 2023, the value increased from 100.45 million USD to 289.06 million USD, representing substantial growth. A more detailed review reveals annual fluctuations with significant spikes as observed in 2016 with a 42.59% increase and in 2018 with a 33.73% increase. Despite a drop in 2022 of 4.47%, the market recovered in 2023 with a 4.74% increase. The 5-year CAGR from 2023 to 2028 is anticipated to be 2.98%, indicating continued growth albeit at a slower rate than historically.
Future trends to watch include:
- An increased demand for advanced pharmaceuticals amidst an aging population.- Potential impact of new healthcare policies and international trade agreements.- Rapid technological advancements in drug development and distribution methods.
